List of Schedule III drugs

List of Schedule III Drugs refers to a classification of controlled substances as defined by various drug control laws in different jurisdictions. Schedule III drugs are considered to have a moderate to low potential for physical and psychological dependence compared to substances listed in Schedules I and II. This category includes a diverse range of substances, from anabolic steroids to certain compounds containing less potent quantities of narcotics. The classification system aims to regulate the manufacture, distribution, and use of these substances to prevent abuse while ensuring they are available for legitimate medical and scientific purposes.

Classification and Examples

Schedule III drugs are characterized by their lower potential for abuse compared to Schedule I and II substances, a currently accepted medical use in treatment in the United States, or a similarly regulated jurisdiction, and the potential for moderate or low physical dependence or high psychological dependence. Examples of substances classified under Schedule III include, but are not limited to:

• Anabolic steroids: Synthetic substances similar to the male sex hormone testosterone, prescribed for treating hormonal issues and muscle loss.
• Ketamine: A medication primarily used for starting and maintaining anesthesia, which also has pain-relieving and memory-loss effects.
• Buprenorphine: Often used in the treatment of opioid addiction, as well as for pain management.
• Certain barbiturates: Used in the treatment of sleep disorders or as anesthesia in surgery.
• Codeine combinations: Medications containing a relatively small amount of codeine, such as certain cough syrups and pain relievers.

Regulation

The regulation of Schedule III drugs varies by country, with each nation having its own controlled substances laws and regulatory agencies. In the United States, the Drug Enforcement Administration (DEA) enforces the Controlled Substances Act (CSA), which classifies drugs into five schedules. The criteria for classification include the drug's acceptable medical use, and the drug's abuse or dependency potential. Other countries, such as Canada and members of the European Union, have their own classifications and regulatory bodies, such as Health Canada and the European Medicines Agency (EMA), respectively.

Implications for Healthcare Professionals

Healthcare professionals must adhere to specific regulatory requirements when prescribing, dispensing, or administering Schedule III drugs. These requirements may include:

• Obtaining a special license or registration from the relevant regulatory body.
• Keeping detailed records of the storage, distribution, and disposal of these substances.
• Limiting the quantity prescribed to patients and, in some jurisdictions, refraining from refilling prescriptions without a new prescription from a healthcare provider.

Legal Consequences

The unauthorized possession, distribution, or manufacture of Schedule III drugs can lead to significant legal penalties, including fines and imprisonment. The severity of these penalties often depends on the quantity of the substance, the individual's intent, and whether the offense involved crossing international borders.

See Also

• Controlled Substances Act
• Drug Enforcement Administration
• Anabolic steroid
• Ketamine
• Buprenorphine
• Codeine

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian